LLMpediaThe first transparent, open encyclopedia generated by LLMs

University of Toronto Research Ethics Board

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 50 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted50
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
University of Toronto Research Ethics Board
NameUniversity of Toronto Research Ethics Board
TypeResearch ethics committee
Established20th century
LocationToronto, Ontario, Canada
Parent organizationUniversity of Toronto

University of Toronto Research Ethics Board

The University of Toronto Research Ethics Board is the institutional committee responsible for the ethical review of human‑participant research at the University of Toronto in Toronto, Ontario, Canada. It operates within the regulatory framework influenced by the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans and interacts with provincial institutions such as the Ontario Ministry of Health and federal entities including Health Canada and the Canadian Institutes of Health Research. The board's decisions affect researchers across faculties linked to units like the Dalla Lana School of Public Health, Faculty of Medicine, and Rotman School of Management.

History and development

The board developed in the late 20th century alongside international responses to ethical failures highlighted by events such as the Tuskegee Syphilis Study, the Nuremberg Trials, and the adoption of the Declaration of Helsinki. Institutional reforms at the University of Toronto followed national discussions prompted by the Krever Commission and policy shifts from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council as reflected in successive editions of the Tri-Council Policy Statement. Over decades the board expanded procedures to address multidisciplinary projects from the Temerty Faculty of Medicine, interdisciplinary initiatives with the Rotman School of Management, and partnerships with hospitals like Toronto General Hospital and research institutes such as the MaRS Discovery District.

Mandate and jurisdiction

The board's mandate is to ensure compliance with regulatory instruments including the Tri-Council Policy Statement, mandates from Health Canada concerning clinical trials, and institutional obligations under the University of Toronto charter. Its jurisdiction covers human‑participant research conducted by faculties and affiliated hospitals such as St. Michael's Hospital, Mount Sinai Hospital (Toronto), and community partnerships with organizations like Public Health Ontario. The board’s remit intersects with professional colleges such as the College of Physicians and Surgeons of Ontario and funding conditions from bodies like the Canadian Cancer Society and CIHR.

Organizational structure and governance

Governance includes a chair, vice‑chairs, scientific reviewers, community representatives, legal advisors, and lay members drawn from constituencies across faculties including the Faculty of Arts and Science, Faculty of Law, and Ontario Institute for Studies in Education. The board reports to university offices such as the Vice-President Research and Innovation and liaises with the Research Ethics Office (University of Toronto). It applies policies shaped by external frameworks from Health Canada, the Public Health Agency of Canada, and provincial statutes enforced by the Ontario Human Rights Commission when relevant. Committees may be convened for specialized review in areas tied to clinical research centers like Princess Margaret Cancer Centre and pediatric research at Hospital for Sick Children.

Ethics review processes and policies

Review processes follow protocols for delegated review, full board review, and expedited review, echoing standards in the Tri-Council Policy Statement and regulatory guidance from Health Canada on clinical trials. Policies address consent procedures informed by precedents like the Declaration of Helsinki and data stewardship reflecting obligations under provincial privacy instruments such as the Personal Health Information Protection Act in Ontario. Specialized policies manage crossover topics involving collaborations with international entities like the World Health Organization and funders including the Bill & Melinda Gates Foundation and the Wellcome Trust. Procedures also cover conflict of interest management aligning with guidelines from bodies such as the Canadian Institutes of Health Research and reporting obligations to oversight agencies like the Ontario Public Guardian and Trustee where guardian consent issues arise.

Researcher responsibilities and training

Researchers must complete mandatory training modules and certifications modeled after programs from organizations like the National Institutes of Health, the Canadian Institutes of Health Research, and institutional modules administered by the University of Toronto Research Ethics Office. Training covers topics including informed consent, vulnerable populations encountered in studies with ties to institutions such as SickKids Research Institute, data management consistent with the Tri-Agency Research Data Management Policy, and compliance with clinical trial registration norms exemplified by ClinicalTrials.gov. Principal investigators affiliated with units like the Dalla Lana School of Public Health or collaborations with the Rotman School of Management are required to attest to oversight practices and to report adverse events to regulatory bodies such as Health Canada and institutional risk offices including the University of Toronto Risk Management Services.

Notable cases and controversies

The board's reviews and decisions have intersected with high‑profile debates involving research ethics at Canadian universities, drawing comparison with controversies at institutions like McGill University and University of British Columbia. Disputes have touched on issues of consent, Indigenous research protocols informed by principles like OCAP (Ownership, Control, Access and Possession), and data sharing in partnerships with international entities such as the European Commission‑funded consortia. Matters have occasionally prompted scrutiny from media outlets and legal challenges referencing statutes administered by bodies like the Ontario Superior Court of Justice and regulatory interpretation tied to the Tri-Council Policy Statement.

Category:Research ethics committees Category:University of Toronto